Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,963 | -47,305 | -46,929 | -38,673 | -39,891 |
| Depreciation Amortization | 348 | 477 | 543 | 576 | 592 |
| Accounts receivable | -30,205 | N/A | 393 | 763 | -649 |
| Accounts payable and accrued liabilities | -4 | -73 | -161 | 159 | 214 |
| Other Working Capital | 70,046 | -2,491 | 1,700 | -3,528 | -452 |
| Other Operating Activity | 38,923 | 10,065 | 10,139 | 7,385 | 7,959 |
| Operating Cash Flow | $39,145 | $-39,327 | $-34,315 | $-33,318 | $-32,227 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -304 | -218 | -352 | -554 | -472 |
| Purchase Of Investment | -136,234 | -24,372 | -100,837 | -136,600 | -177,566 |
| Sale Of Investment | 87,774 | 58,474 | 139,528 | 105,486 | 121,134 |
| Investing Cash Flow | $-48,764 | $33,884 | $38,339 | $-31,668 | $-56,904 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -330 | -571 | -547 |
| Common Stock Issued | 8,820 | 2,191 | 2,123 | 67,355 | 57,983 |
| Financing Cash Flow | $8,820 | $2,191 | $1,793 | $66,784 | $57,436 |
| Beginning Cash Position | 12,823 | 16,075 | 10,258 | 8,460 | 40,155 |
| End Cash Position | 12,024 | 12,823 | 16,075 | 10,258 | 8,460 |
| Net Cash Flow | $-799 | $-3,252 | $5,817 | $1,798 | $-31,695 |
| Free Cash Flow | |||||
| Operating Cash Flow | 39,145 | -39,327 | -34,315 | -33,318 | -32,227 |
| Capital Expenditure | -304 | -218 | -352 | -554 | -472 |
| Free Cash Flow | 38,841 | -39,545 | -34,667 | -33,872 | -32,699 |